Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Nicky J Welton

University of Bristol

United Kingdom

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Biostatistics

70%

Health Economics

40%

Randomized Controlled Trial

50%

Meta-analysis

50%

Patient Selection

30%

Multicentre Study

20%

Major Depressive Disorder

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

The benefits, harms and costs of surveillance for hepatocellular carcinoma in people with cirrhosis: synthesis of observational and diagnostic test accuracy data and cost–utility analysis.

Open Date: 2022-07-01

Close Date: 2024-03-01

Grant: Open

Production of Technology Assessment Reviews (TARs) for the National Institute for Health Research (NIHR).

Open Date: 2022-04-01

Close Date: 2027-03-01

Grant: Close

Real-world treatment effectiveness in people with type 2 diabetes: Maximising the applicability of clinical trials

Open Date: 2020-02-01

Close Date: 2023-02-01

Grant: Close

A comprehensive model and economic evaluation of HCV elimination amongst people who inject drugs in England to guide case-finding intervention policy and implementation.

Open Date: 2020-01-01

Close Date: 2022-12-01

Grant: Close

NIHR HPRU Behavioural Science and Evaluation at University of Bristol

Open Date: 2020-01-01

Close Date: 2025-12-01

Nicky J Welton

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Recent Grants

Articles30

A methodological review of network meta-analyses applied to complex interventions for public health and a typology of the node-making process

Synthesis of depression outcomes reported on different scales: A comparison of methods for modelling mean differences

Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events.

QbTest for ADHD assessment and medication management

Modeling rates of trial attrition: an analysis of individual participant data from 90 randomized controlled trials of pharmacological interventions for multiple conditions

Using a Markov model and real-world evidence to identify the most cost-effective cholesterol treatment escalation threshold for the secondary prevention of cardiovascular disease

Age and sex differences in efficacy of treatments for type 2 diabetes

Quantitative bias analysis for unmeasured confounding in unanchored population-adjusted indirect comparisons

Individual participant data network meta-analysis of psychosocial interventions for survivors of intimate partner violence

Effect modification and non-collapsibility together may lead to conflicting treatment decisions

Advancing unanchored simulated treatment comparisons: a novel implementation and simulation study

Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review

Prevalence of opioid dependence in Scotland 2015-2020

A systematic review and network meta-analysis of psychological, psychosocial, pharmacological, physical and combined treatments for adults with a new episode of depression

Response to discussant comments on “NMA, the first 20 years”

Twenty years of network meta‐analysis: Continuing controversies and recent developments

MPES-R

Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions

Value of Information for Clinical Trial Design: The Importance of Considering All Relevant Comparators

Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery

Validating the Assumptions of Population Adjustment: Application of Multilevel Network Meta-regression to a Network of Treatments for Plaque Psoriasis

Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta-analysis

General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations

Resistance Training Prescription for Muscle Strength and Hypertrophy in Healthy Adults

Constructing Relative Effect Priors for Research Prioritization and Trial Design

What is the optimal management of potentially resectable stage III-N2 NSCLC? Results of a fixed-effects network meta-analysis and economic modelling

Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol

A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris

Assessing trial representativeness using Serious Adverse Events

NICE guidance on nivolumab plus ipilimumab for untreated, unresectable malignant pleural mesothelioma

Collaborators18

Neal Navani

Tony Ades

Josephine Walker

Mark Strong

G.J. Melendez-Torres

Hayley E Jones

Alan Yeung

Lise Estcourt

Sofia Dias

Deborah Caldwell

Ifigeneia Mavranezouli

Dina Janković

Mariska Leeflang

Miles Witham

Shijie Ren

Gianluca Baio

Torbjørn Wisløff

Riyaz Patel

How do I reach out?